MICHELLE CICCONE: Open Payments
NPI 1497325385 · SAYRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 47 payments from 12 companies in 2025. Trend: 2023 $954 · 2024 $1,196 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $160 |
| ABBVIE INC. | 10 | $149 |
| Eisai Inc. | 3 | $148 |
| Novartis Pharmaceuticals Corporation | 7 | $118 |
| UCB, Inc. | 3 | $115 |
| TG Therapeutics, Inc. | 2 | $114 |
| Neurocrine BioSciences, Inc. | 3 | $103 |
| AstraZeneca Pharmaceuticals LP | 2 | $80 |
| ARGENX US, INC. | 1 | $60 |
| JAZZ PHARMACEUTICALS INC. | 1 | $57 |
Products named: NURTEC ODT, Leqembi, KESIMPTA, BRIUMVI, INGREZZA, QULIPTA, VYVGART, BOTOX.
Industry payments across PA — which companies pay providers there.
